Healthcare

🧬 Arginine and Alzheimer's: An inexpensive, clinically safe amino acid reduces amyloid plaques in animal models, opening a low-cost repositioning pathway toward Alzheimer's prevention therapy. 💉 IV Biomaterial Heals Cardiac Tissue: A UC San Diego hydrogel delivered intravenously travels through the bloodstream to repair heart attack damage and reduce inflammation, with human trials targeted within two years. 🦠 Hidden Gut Bacteria Linked to Global Health: CAG-170, found in elevated abundance in healthy individuals across 39 countries, produces vitamin B12 and may become the next generation of targeted probiotic therapy. 🤖 AI Drug Pipeline Crosses 173 Clinical Programs: With 15 to 20 AI-discovered drugs entering pivotal trials this year, AI has crossed from experimental tool to operational standard in pharmaceutical development. 💪 Grip Strength Predicts Longevity Independently: Muscle strength in women over 60 predicts survival even without meeting aerobic exercise targets, establishing strength training as an independent longevity intervention in its own right.

☕ Coffee and the Gut-Brain Axis — A Nature Communications study of 62 adults found both caffeinated and decaf coffee reshape gut microbiome composition in ways tied to better mood, memory, and stress resilience. 🏆 Bowel Cancer Trial: Zero Relapses at 33 Months — The NEOPRISM-CRC trial found nine weeks of pre-surgical pembrolizumab kept 100% of MMR-deficient colorectal cancer patients relapse-free well past the three-year mark. ⌚ Wrist Wearables Now Measure Biological Age — PpgAge, built from 213,000 Apple Study participants, predicts heart disease and diabetes onset from a wristwatch sensor, pushing consumer health into clinical biomarker territory. 💊 AI Drug Discovery Reaches Phase I — XtalPi's AI-discovered PRMT5 inhibitor PEP08 enrolled its first patients in a Phase I solid tumor trial, adding to 173 AI-discovered compounds now in human trials globally. 🏋️ GLP-1 and Muscle Loss Demand Clinical Action — Up to 40% of weight lost on GLP-1 drugs is lean muscle, and a JAMA perspective argues structured exercise must be co-prescribed as a clinical standard, not a lifestyle afterthought.